Compare Stocks

Enter up to five stock symbols separated by a comma or space (e.x BAC,WFC,JPM,LON:BARC).
 

 Cumberland PharmaceuticalsOvid TherapeuticsArbutus BiopharmaKezar Life SciencesCatabasis Pharmaceuticals
SymbolNASDAQ:CPIXNASDAQ:OVIDNASDAQ:ABUSNASDAQ:KZRNASDAQ:CATB
Price Information
Current Price$4.86$2.36$1.66$3.77$6.00
52 Week RangeN/ABuyHoldBuyBuy
Analyst Ratings
Consensus RecommendationN/ABuyHoldBuyBuy
Consensus Price TargetN/A$14.80$6.3333$15.00$47.50
% Upside from Price TargetN/A527.12% upside281.53% upside297.88% upside691.67% upside
Trade Information
Market Cap$77.94 million$94.02 million$94.94 million$67.18 million$70.05 million
Beta0.152.281.660.871.75
Average Volume29,402373,642159,61696,40233,772
Sales & Book Value
Annual Revenue$40.74 millionN/A$5.90 millionN/A$500,000.00
Price / Sales1.83N/A16.00N/A139.44
Cashflow$0.0717 per shareN/AN/AN/AN/A
Price / Cash67.81N/AN/AN/AN/A
Book Value$3.58 per share$1.57 per share$1.33 per share$5.69 per share$4.89 per share
Price / Book1.36N/A1.25N/A1.23
Profitability
Net Income$-6,960,000.00$-51,980,000.00$-57,060,000.00$-23,170,000.00$-25,870,000.00
EPS($0.12)($2.11)($1.02)($2.26)($5.12)
Trailing P/E Ratio29.82N/A0.00N/A0.00
Forward P/E Ratio11.57N/AN/AN/AN/A
P/E GrowthN/AN/AN/AN/AN/A
Net Margins-9.87%N/A-1,948.40%N/AN/A
Return on Equity (ROE)5.04%-110.14%-125.64%-26.50%-59.06%
Return on Assets (ROA)2.65%-91.84%-36.05%-24.54%-53.31%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio0.37%0.01%0.10%0.06%N/A
Current Ratio2.33%5.84%11.32%20.32%9.09%
Quick Ratio1.85%5.84%11.32%20.32%9.09%
Ownership Information
Institutional Ownership Percentage31.03%26.16%36.49%52.27%37.63%
Insider Ownership Percentage39.38%29.80%9.60%11.90%3.20%
Miscellaneous
Employees8055792424
Shares Outstanding15.37 million38.69 million56.85 million19.14 million11.62 million
Next Earnings Date11/12/2019 (Estimated)11/14/2019 (Estimated)11/6/2019 (Estimated)11/14/2019 (Estimated)11/12/2019 (Estimated)
OptionableOptionableNot OptionableOptionableNot OptionableNot Optionable
 Cumberland PharmaceuticalsOvid TherapeuticsArbutus BiopharmaKezar Life SciencesCatabasis Pharmaceuticals

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel